News
UTHR ▼ -0.1% - United Therapeutics Corporation
UTHR ▼ -0.1% - United Therapeutics Corporation
$UTHR United Therapeutics Corporation Announces First Transplant in EXTEND Clinical Trial of UThymoKidney™ in Patients with End-Stage Renal Disease
20-NOV-2026 07:00 AM ET
Share this post
More filings for $UTHR
UTHR - United Therapeutics Corporation - SEC Filing Update (04-NOV-2026) | ThinkSabio - Stocks SimplifiedNov 4, 2026UTHR ▲ +0.6% - United Therapeutics CorporationNov 4, 2026UTHR ▲ +0.0% - United Therapeutics CorporationOct 28, 2026UTHR ▲ +1.5% - United Therapeutics CorporationOct 1, 2026UTHR ▼ -1.9% - United Therapeutics CorporationSep 24, 2026UTHR ▲ +1.2% - United Therapeutics CorporationSep 8, 2026
View full $UTHR filing history →💬 Comments
Loading comments…
Leave a comment
